Nexalin Technology Share Price (NASDAQ: NXL)

$0.96

▲

0.04

(4.35%)

Last updated on August 30, 2025 at 1:28 am IST

$₹

Check the interactive Nexalin Technology Stock chart to analyse performance

Nexalin Technology stock performance

as on August 30, 2025 at 1:28 am IST

Today's Low:$0.93
Today's High:$0.97
$0.96
2.72%
Downside
Day's Volatility :3.72%
Upside
1.03%
52 Weeks Low:$0.59
52 Weeks High:$4.49
$0.96
38.44%
Downside
52 Weeks Volatility :86.84%
Upside
78.62%

Nexalin Technology Stock Returns

Period	Nexalin Technology Inc	Index (Russel 2000)
3 Months	-21.54%	0.0%
6 Months	-60.45%	0.0%
1 Year	6.36%	0.0%
3 Years	-57.46%	-4.7%

Nexalin Technology Inc Key Stats

Check Nexalin Technology key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.92
Open	$0.9345
Today's High	$0.97
Today's Low	$0.9339
Market Capitalization	$16.0M
Today's Volume	$380.4K
52 Week High	$4.4899
52 Week Low	$0.591
Revenue TTM	$174.8K
EBITDA	$-9.0M
Earnings Per Share (EPS)	$-0.77
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-242.01%

Stock Returns calculator for Nexalin Technology Stock including INR - Dollar returns

The Nexalin Technology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Nexalin Technology investment value today

Current value as on today

₹1,09,632

Returns

₹9,632

(+9.63%)

Returns from Nexalin Technology Stock

₹4,348 (+4.35%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Nexalin Technology Stock

133%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Nexalin Technology Stock from India on INDmoney has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Nexalin Technology Stock

Rating

Trend

Nexalin Technology Share Price Target

What analysts predicted

Upside of 316.67%

Target:

$4.00

Current:

$0.96

Nexalin Technology share price target is $4.00, a slight Upside of 316.67% compared to current price of $0.96 as per analysts' prediction.

Nexalin Technology Stock Insights

Price Movement
In the last 6 months, NXL stock has moved down by -64.7%
Increasing Revenue
Revenue is up for the last 3 quarters, 27.17K → 70.58K (in $), with an average increase of 37.8% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -2.83M → -1.58M (in $), with an average increase of 34.1% per quarter
NXL vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 25.1%
Price to Sales
ForNXL every $1 of sales, investors are willing to pay $68.4, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Nexalin Technology Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$207.4K	-
Net Income	$-5.0M	-
Net Profit Margin	-2.4K%	-

	FY20	Y/Y Change
Revenue	$242.9K	↑ 17.13%
Net Income	$-3.4M	↓ 32.22%
Net Profit Margin	-1.4K%	↑ 1020.11%

	FY21	Y/Y Change
Revenue	$144.1K	↓ 40.69%
Net Income	$-6.1M	↑ 78.58%
Net Profit Margin	-4.2K%	↓ 2817.82%

	FY22	Y/Y Change
Revenue	$1.3M	↑ 817.2%
Net Income	$-1.7M	↓ 72.07%
Net Profit Margin	-128.49%	↑ 4090.44%

	FY23	Y/Y Change
Revenue	$110.7K	↓ 91.62%
Net Income	$-4.6M	↑ 173.81%
Net Profit Margin	-4.2K%	↓ 4069.07%

	FY24	Y/Y Change
Revenue	$168.7K	↑ 52.35%
Net Income	$-7.6M	↑ 63.64%
Net Profit Margin	-4.5K%	↓ 311.17%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$78.7K	↑ 283.09%
Net Income	$-1.0M	↑ 33.37%
Net Profit Margin	-1.3K%	↑ 2478.04%

	Q2 FY24	Q/Q Change
Revenue	$26.8K	↓ 65.88%
Net Income	$-1.3M	↑ 23.37%
Net Profit Margin	-4.8K%	↓ 3462.31%

	Q3 FY24	Q/Q Change
Revenue	$36.0K	↑ 34.24%
Net Income	$-2.4M	↑ 90.6%
Net Profit Margin	-6.8K%	↓ 2009.12%

	Q4 FY24	Q/Q Change
Revenue	$27.2K	↓ 24.57%
Net Income	$-2.8M	↑ 15.73%
Net Profit Margin	-10.4K%	↓ 3629.64%

	Q1 FY25	Q/Q Change
Revenue	$41.0K	↑ 50.91%
Net Income	$-2.0M	↓ 29.82%
Net Profit Margin	-4.8K%	↑ 5576.67%

	Q2 FY25	Q/Q Change
Revenue	$70.6K	↑ 72.1%
Net Income	$-1.6M	↓ 20.49%
Net Profit Margin	-2.2K%	↑ 2608.09%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-10.8K	-

	FY20	Y/Y Change
Profit	$213.9K	↓ 2075.39%

	FY21	Y/Y Change
Profit	$122.6K	↓ 42.67%

	FY22	Y/Y Change
Profit	$958.1K	↑ 681.37%

	FY23	Y/Y Change
Profit	$85.1K	↓ 91.12%

	FY24	Y/Y Change
Profit	$132.1K	↑ 55.34%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$69.5K	↓ 117.1%

	Q2 FY24	Q/Q Change
Profit	$19.6K	↓ 71.81%

	Q3 FY24	Q/Q Change
Profit	$23.3K	↑ 19.11%

	Q4 FY24	Q/Q Change
Profit	$19.7K	↓ 15.66%

	Q1 FY25	Q/Q Change
Profit	$27.5K	↑ 39.5%

	Q2 FY25	Q/Q Change
Profit	$47.8K	↑ 73.91%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-678.3K	-
Investing Cash Flow	$-648.0	-
Financing Cash Flow	$726.1K	-

	FY20	Y/Y Change
Operating Cash Flow	$-863.5K	↑ 27.29%
Investing Cash Flow	$-648.0	↑ 0.0%
Financing Cash Flow	$879.1K	↑ 21.08%

	FY21	Y/Y Change
Operating Cash Flow	$-1.1M	↑ 24.7%
Investing Cash Flow	$-6.8M	↑ 1048492.44%
Financing Cash Flow	$1.7M	↑ 88.84%

	FY22	Y/Y Change
Operating Cash Flow	$-2.2M	↑ 105.77%
Investing Cash Flow	$-6.8M	↑ 0.0%
Financing Cash Flow	$8.5M	↑ 412.7%

	FY23	Y/Y Change
Operating Cash Flow	$-3.8M	↑ 73.1%
Investing Cash Flow	$4.5M	↓ 165.53%
Financing Cash Flow	$-200.0K	↓ 102.35%

	FY24	Y/Y Change
Operating Cash Flow	$-3.9M	↑ 2.84%
Investing Cash Flow	$-577.5K	↓ 112.97%
Financing Cash Flow	$4.5M	↓ 2358.09%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-763.3K	↓ 23.98%
Investing Cash Flow	$729.3K	↓ 40.36%
Financing Cash Flow	$0.0	-

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-1.2M	↑ 63.3%
Investing Cash Flow	$1.5M	↑ 112.39%
Financing Cash Flow	$0.0	-

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-800.2K	↓ 35.8%
Investing Cash Flow	$-4.5M	↓ 389.44%
Financing Cash Flow	$4.5M	-

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-1.1M	↑ 41.77%
Investing Cash Flow	$1.6M	↓ 136.3%
Financing Cash Flow	$0.0	↓ 100.0%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-917.2K	↓ 35.69%
Investing Cash Flow	$-3.9M	↓ 365.98%
Financing Cash Flow	$4.6M	-

Nexalin Technology Technicals Summary

Sell

Neutral

Buy

Nexalin Technology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Nexalin Technology Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nexalin Technology Inc	-4.28%	-60.45%	6.36%	-57.46%	-57.46%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nexalin Technology Inc	NA	NA	NA	-0.49	-2.42	-1.39	NA	0.34
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nexalin Technology Inc	NA	$16.0M	-57.46%	NA	0.0%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Nexalin Technology Inc

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Organization	Nexalin Technology
Employees	6
CEO	Mr. Mark White
Industry	Miscellaneous

Key Management of Nexalin Technology Inc

Name	Title
Mr. Mark White	President, CEO & Director
Ms. Carolyn Shelton	Executive VP of Clinical, Quality & Regulatory Affairs and COO
Dr. David Owens M.D.	Chief Medical Officer, Member of Scientific Advisory Board & Director
Ms. Marilyn Elson	Controller
Mr. John Patrick Claude	Co-Founder and Director of Engineering & Development
Mr. Justin Van Fleet CPA	Chief Financial Officer

Important FAQs about investing in NXL Stock from India :

What is Nexalin Technology share price today?

Nexalin Technology share price today is $0.96 as on August 30, 2025 at 1:28 am IST at the close of the market. Nexalin Technology share today touched a day high of $0.97 and a low of $0.93.

What is the 52 week high and 52 week low for Nexalin Technology share?

Nexalin Technology share touched a 52 week high of $4.49 and a 52 week low of $0.59. Nexalin Technology stock price today i.e. August 30, 2025 at 1:28 am IST is closed at $0.96, lower by 78.62% versus the 52 week high.

How to invest in Nexalin Technology Stock (NXL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nexalin Technology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nexalin Technology Shares that will get you 1.5625 shares as per Nexalin Technology share price of $0.96 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Nexalin Technology Stock (NXL) from India?

Indian investors can start investing in Nexalin Technology (NXL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Nexalin Technology stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Nexalin Technology share’s latest price of $0.96 as on August 30, 2025 at 1:28 am IST, you will get 10.4167 shares of Nexalin Technology. Learn more about fractional shares .

What are the returns that Nexalin Technology has given to Indian investors in the last 5 years?

Nexalin Technology stock has given -57.46% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?